GMED — Globus Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $6.86bn
- $6.76bn
- $1.57bn
- 85
- 33
- 55
- 59
Annual cashflow statement for Globus Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 155 | 102 | 149 | 190 | 123 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 33.2 | 75.6 | 92.1 | 47.5 | 150 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -73.4 | -37.6 | -17.3 | -105 | -117 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | 172 | 199 | 276 | 178 | 243 |
| Capital Expenditures | -70.8 | -63.7 | -56.9 | -74 | -78.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -69.5 | -53.7 | -319 | -36.3 | 381 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -140 | -117 | -376 | -110 | 303 |
| Financing Cash Flow Items | -6.6 | -6.32 | -9.35 | -7.18 | -18.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 24.4 | -38.7 | 54.1 | -110 | -232 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 56 | 43.7 | -46.3 | -42.6 | 317 |